2-Allylphenol

2-Allylphenol

SCHEMBL252949

C=CCc1ccccc1O.CCOCC.OCCO

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.42
GABRB2 P47870 4/20 0.42
AKR1B1 P15121 1/20 0.40
HSPA5 P11021 1/20 0.38
POLB P06746 1/20 0.37
KDM4E B2RXH2 2/20 0.37
HSD17B10 Q99714 1/20 0.37
IDO1 P14902 2/20 0.37
ALDH1A1 P00352 1/20 0.37
HTR1A P08908 1/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Allylphenol SCHEMBL184203 0.95 GABRA1 (0.46) GABRA1GABRB2AKR1B1HSPA5POLB
2-Allylphenol SCHEMBL170457 0.93 GABRA1 (0.44) GABRA1GABRB2AKR1B1HSPA5POLB
2-Allylphenol SCHEMBL10583297 0.93 GABRA1 (0.44) GABRA1GABRB2AKR1B1HSPA5POLB
2-Allylphenol SCHEMBL1135673 0.93 GABRA1 (0.44) GABRA1GABRB2AKR1B1HSPA5POLB
2-Allylphenol SCHEMBL28764863 0.92 GABRA1 (0.43) GABRA1GABRB2AKR1B1HSPA5POLB
2-Allylphenol SCHEMBL11259874 0.88 ALDH1A1 (0.42) GABRA1GABRB2AKR1B1KDM4EALDH1A1
2-Allylphenol SCHEMBL176552 0.88 GABRA1 (0.52) GABRA1GABRB2AKR1B1HSPA5POLB
2-Allylphenol SCHEMBL16296431 0.88 GABRA1 (0.44) GABRA1GABRB2AKR1B1HSPA5POLB
2-Allylphenol SCHEMBL2526225 0.88 GABRA1 (0.40) GABRA1GABRB2AKR1B1HSPA5POLB
2-Allylphenol SCHEMBL10534621 0.86 GABRA1 (0.47) GABRA1GABRB2AKR1B1HSPA5POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 578 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3801030-A1 METHODS OF PROTECTING A PLANT FROM FUNGAL PESTS Novozymes BioAG A/S (DK) 2021-04-14 EP claimed
EP-3801017-A1 METHODS OF PROTECTING A PLANT FROM INSECT PESTS Novozymes Bioag A/S (DK) 2021-04-14 EP claimed
CN-112312974-A Hair dyeing compositions comprising oxidation dyes, scleroglucan gums and associative cellulosic polymers 莱雅公司 2021-02-02 CN claimed
EP-3749094-A2 METHODS OF PROTECTING A PLANT FROM FUNGAL PESTS Novozymes BioAG A/S (DK) 2020-12-16 EP claimed
WO-2019157061-A2 METHODS OF PROTECTING A PLANT FROM FUNGAL PESTS NOVOZYMES BIOAG A/S (DK) 2019-08-15 WO claimed
EP-3397746-A1 STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME Novozymes BioAG A/S (DK) 2018-11-07 EP claimed
EP-3397778-A1 STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME Novozymes BioAG A/S (DK) 2018-11-07 EP claimed
WO-2017116846-A1 STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME NOVOZYMES BIOAG A/S (DK) 2017-07-06 WO claimed
WO-2017116837-A1 STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME NOVOZYMES BIOAG A/S (DK) 2017-07-06 WO claimed
EP-2854751-B1 USE OF N-METHYL-N-ACYLGLUCAMINES AS SOLUBILIZERS CLARIANT INT LTD (CH) 2016-08-10 EP claimed
CN-102007084-A Rheology influencing additive for mineral building materials AKZO NOBEL NV 2011-04-06 CN claimed
EP-2297060-A1 RHEOLOGY INFLUENCING ADDITIVE FOR MINERAL BUILDING MATERIALS Akzo Nobel N.V. (NL) 2011-03-23 EP claimed
US-20110039984-A1 RHEOLOGY INFLUENCING ADDITIVE FOR MINERAL BUILDING MATERIALS AKZO NOBEL N.V. (NL) 2011-02-17 US claimed
WO-2009144081-A1 RHEOLOGY INFLUENCING ADDITIVE FOR MINERAL BUILDING MATERIALS AKZO NOBEL N.V. (NL) 2009-12-03 WO claimed
US-20080107617-A1 Surfactant-containing cosmetic, dermatological and pharmaceutical agents CLARIANT PRODUKTE (DEUTSCHLAND) GMBH 2008-05-08 US claimed
US-7332155-B2 Surfactant-containing cosmetic, dermatological and pharmaceutical agents CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) 2008-02-19 US claimed
US-6946139-B2 Methods for producing foam from multiphase compositions CLARIANT GMBH (DE) 2005-09-20 US claimed
EP-0998257-B1 OXIDISING COMPOSITION AND USES FOR TREATING KERATIN FIBRES OREAL (FR) 2004-11-17 EP claimed
US-20040141937-A1 comprising comb copolymers based on acryloyldimethyltaurine CLARIANT GMBH (DE) 2004-07-22 US claimed
US-20040105825-A1 Methods for producing foam from multiphase compositions CLARIANT GMBH 2004-06-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040141937-A1 comprising comb copolymers based on acryloyldimethyltaurine ATIC, PCNA, FEN1 GABRA1 4017/4885GABRB2 4509/4885AKR1B1 1216/4885
US-20080107617-A1 Surfactant-containing cosmetic, dermatological and pharmaceutical agents SGMS1, SUCLG1, SGMS2 GABRA1 3329/4885GABRB2 4202/4885AKR1B1 978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.